ZIP6 was first discovered as an oestrogen-regulated gene [30] present in breast cancers with lymph node involvement [31] and more recently used as a biomarker of oestrogen-receptor-positive luminal-type-A breast cancer [32, 33], a relationship confirmed both in cell lines and clinical material [34]. This evidence concerns the gene SLC39A6 and breast carcinoma.